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Abstract
We have developed a technique for the high-resolution, self-aligning, and high-throughput patterning of antibody
binding functionality on surfaces by selectively changing the reactivity of protein-coated surfaces in speciﬁc regions of
a workpiece with a beam of energetic helium particles. The exposed areas are passivated with bovine serum albumin
(BSA) and no longer bind the antigen. We demonstrate that patterns can be formed (1) by using a stencil mask with
etched openings that forms a patterned exposure, or (2) by using angled exposure to cast shadows of existing raised
microstructures on the surface to form self-aligned patterns. We demonstrate the eﬃcacy of this process through the
patterning of anti-lysozyme, anti-Norwalk virus, and anti-Escherichia coli antibodies and the subsequent detection of
each of their targets by the enzyme-mediated formation of colored or silver deposits, and also by binding of gold
nanoparticles. The process allows for the patterning of three-dimensional structures by inclining the sample relative to
the beam so that the shadowed regions remain unaltered. We demonstrate that the resolution of the patterning
process is of the order of hundreds of nanometers, and that the approach is well-suited for high throughput patterning.
Background
Creating patterned biological functionality of antibod-
ies, enzymes, or cell-adhesion molecules is an essential
tool for the development of high-performance bioanalyt-
ical devices and diagnostics. Patterned antibody surfaces
have previously been formed by ultraviolet (UV) [1-3]
and electron beam [4-6] exposure of polymeric ﬁlms,
followed by a development step to create two chemically-
distinct surfaces which can be selectively functional-
ized. These approaches take advantage of well-established
lithographic techniques and can achieve very high spatial
resolution on planar substrates. Stamping techniques also
have been developed to transfer chemically-orthogonal
self-assembled monolayers (SAMs) to surfaces by ink-
ing a stamp, typically made of polydimethylsiloxane, with
*Correspondence: PRuchhoeft@UH.edu
2Department of Electrical and Computer Engineering, University of Houston,
Houston, TX, USA
3Department of Biomedical Engineering, University of Houston, Houston,
TX, USA
4Materials Engineering, University of Houston, Houston, TX, USA
Full list of author information is available at the end of the article
the SAM molecule and transferring it from the protru-
sions on the stamp directly onto the substrate [7,8]. Direct
“writing” of SAMs using an AFM tip has also been demon-
strated [9,10], and nanopipette delivery of biomolecules
to speciﬁc areas of a previously etched surface also has
been developed [11-13]. While these techniques are well
established and extremely useful, none are well-suited
for patterning surfaces with three-dimensional structures
without the need for precise alignment with the existing
patterns; an approach to this problem is the subject of the
present work.
We are developing a biosensing platform in which the
brightness of microfabricated retroreﬂecting structures is
modulated in the presence of analyte by capture of opaci-
fying elements, especially magnetic sample-prep particles.
To simplify readout, we form reference retroreﬂectors
proximal to assay reﬂectors so that the brightness of these
structures can be compared in a single image frame to
monitor changes in the assay region. The schematic in
Figure 1a shows three-dimensional retroreﬂective protru-
sions that reﬂect light back to its source.
© 2013 Cacao et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
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Figure 1Micron-scale retroreﬂector-based read-out. (a) A schematic of a retroreﬂector-based readout with micron-scale sensing areas, where
the brightness of light reﬂected from the central reﬂector is modulated by the analyte-driven assembly of scattering elements. The readout relies on
detecting an intensity change relative to the three always-bright reference reﬂectors, and, thus, the ability selectively to localize the antibodies in
front of the central reﬂector is important and the motivation for this work. (b) Scanning electron microscope images of the ﬁrst-generation (left) and
the second-generation (right) reﬂectors used in this work. (c) A top-down optical microscope image (left) and the corresponding retroreﬂector (RR)
optical readout (right) of nine sets of four reﬂectors, where the a group identiﬁcation number (i.e., four reﬂectors, or a tetrad) and the gray-scale ratio
of assay signal to the average of the three reference signals for each group of four reﬂectors are shown. For the optical readout, the camera is tilted
about 35 degrees.
The structures consist of two perpendicular, mirrored
surfaces so that light entering the structures reﬂects from
both surfaces to return to its source. The more common
retroreﬂecting design that is used in street and sign mark-
ings consist of three mirrored surfaces, which allows them
to appear bright for a wide range of azimuthal orienta-
tions; the structures used in this work retroreﬂect only for
a ﬁxed azimuth but over a wide range of altitudes, requir-
ing alignment in one direction. The image that is formed
consists of four bright spots, each corresponding to the
reﬂections from the longer walls of the structures.
With this design, the three outer reﬂectors produce
an always-bright reference signal for simple identiﬁca-
tion by automated image recognition algorithms and
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Figure 2 Protein patterning by helium-beam antibody modiﬁcation followed by BSA passivation. (a) A top-down beam exposure through a
mask allows for selective inactivation of the transparent regions of the mask, while (b) a self-aligned beam exposure of the micro-retroreﬂector
structures allowed for formation of patterns in the regions where shadows are cast.
normalization of the reﬂectivity of the central assay
reﬂector, which is responsive to analyte. Figure 1b
shows scanning electron microscope (SEM) images of
ﬁrst-generation rectangular retroreﬂectors (left), and
second-generation tapered structures (right). The second-
generation geometry was designed to experience lower
shear forces when ﬂuid ﬂows in the horizontal direction
across the structure while still reﬂecting light from the
longer sidewalls. In the presence of the target, the assay
reﬂector brightness decreases when the analyte captured
in the assay region (left-hand image in Figure 1c) is labeled
with eﬀective light scattering structures that attenuate the
reﬂected signal. Automated image analysis techniques can
identify the structures and calculate the ratio of the assay
reﬂector brightness to those of the references, as illus-
trated in the right-hand image of Figure 1c. The ratio of
the intensity of the assay (central reﬂector) region to the
average of the three reference regions is shown alongside
a region identiﬁer.
We therefore are interested in developing a patterning
process that can (1) take advantage of the presence of
three-dimensional structures to avoid the need to align
a second pattern to the existing structures and (2) pat-
tern surfaces with a large degree of topography and with
high throughput. To address this problem, we have devel-
oped a method for casting shadows of a broad, energetic
(5–7 keV) helium ion beam and for using this beam to
locally modify the activity of a surface uniformly coated
with antibodies. Because of the wavelength of these par-
ticles is extremely small, this approach has a very large
depth of ﬁeld and can cast high quality shadows over long
distances.
Methods
Antibodies
Polyclonal rabbit anti-Escherichia coli (E. coli) antibodies
(20-ER13) were from Fitzgerald Industries International
(Acton, MA) and polyclonal rabbit anti-Norwalk virus-
like particle (NVLP) antibodies were provided by one
of the authors (RLA) [14]. Polyclonal goat anti-rabbit
(R2004) and polyclonal goat anti-mouse (M8645) anti-
bodies were purchased from Sigma-Aldrich (St. Louis,
MO). Goat anti-mouse antibodies conjugated with alka-
line phosphatase (DC05L) were from Calbiochem (EMD
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Figure 3 Images of antibody-coated surfaces patterned by helium beam exposure through a 45 μm-meshmask. (a) An optical microscope
image of patterned monoclonal HyHEL-5 antibodies directly detected with goat anti-mouse antibodies conjugated to alkaline phosphatase and
BCIP-NBT substrate. (b) SEM image of patterned biotinylated polyclonal goat anti-rabbit antibodies directly detected using silver staining of
streptavidin-gold conjugates. (c) An optical microscope image of BCIP-NBT stained E. coli bacteria captured on patterned polyclonal anti-E.coli
antibodies on a gold surface.
Biosciences, Gibbstown, NJ), andmonoclonal mouse anti-
lysozyme antibodies [15] (HyHEL-5) were prepared for
us by Biovest (Minneapolis, MN). All biotinylated anti-
bodies were prepared using the EZ-Link Sulfo-NHS-
LC-Biotinylation Kit (21435, Pierce Protein Research
Products, Thermo Scientiﬁc, Rockford, IL).
Surface preparation
The retroreﬂector structures were formed using meth-
ods similar to those described in ref. [16]. First, 100 mm
diameter silicon wafers were coated with a 5 μm layer
of polyimide (Durimide 10/32, Fujiﬁlm Electronic Mate-
rials, North Kingstown, RI) by spin-casting (1000 rpm for
2 minutes), and the sample was baked at 350°C for 60
minutes on a hot plate. Next, a 300 nm thick layer of
poly(methyl glutarimide) (PMGI) (SF-6 from Microchem
Inc., Newton, MA) was also deposited by spin-casting
(2000 rpm for 2 minutes) and baked at 180°C for 5 min-
utes, followed by a 200 nm thick layer of poly(methyl
methacrylate) (PMMA) (Microchem Inc., Newton, MA)
(2000 rpm for 1 minute), and baked at 180°C for 60
minutes.
The PMMA layer was patterned by electron beam
lithography to form the retroreﬂector structures and
developed for 30 seconds in a 1:3 solution of methyl
isobutyl ketone and isopropanol (MIBK:IPA), which
dissolves the exposed PMMA, and rinsed in IPA before
drying in nitrogen. The PMGI was etched in 2.3% tetram-
ethyl ammonium hydroxide (TMAH) in water for 20 sec-
onds, and a 140 nm thick layer of nickel was deposited
on the wafer by thermal evaporation. The PMMA was
then dissolved in acetone, which removed the nickel in all
regions of the wafer, except where the PMMA was pat-
terned. An oxygen reactive ion etch step in amagnetically-
enhanced, capacitively-coupled plasma reactor (1 mTorr
and 30 watts) transferred the patterns into the polyimide
layer with near-vertical sidewalls. Lastly, the structures
were coated with a 100 nm thick layer of conformal gold
by thermal evaporation.
These gold surfaces were alkanethiol SAM function-
alized using the homobifunctional, thiol-cleavable cross-
linker DSP (dithiobis-succinimidyl propionate) which has
been employed in many biomedical applications [17-19].
The sulfur in the thiol group has strong speciﬁc interac-
tion with gold while the N-hydroxy-succinimide (NHS)
ester reacts with primary amines present in antibodies.
Surfaces were ﬁrst cleaned by dipping them in anhydrous
ethanol for at least 2 minutes, then thoroughly rinsed with
deionized water (18 M), and ﬁnally dried with a stream
of compressed nitrogen. The clean surfaces were then
immersed into a 10 mM solution of DSP (22585, Pierce
Protein Research Products, Thermo Scientiﬁc, Rockford,
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Figure 4 Antibody patterning by self-aligned helium beam exposure of micro-retroreﬂector tetrad. (a) Optical microscope image of
patterned polyclonal goat anti-mouse antibodies directly detected by biotinylated mouse HyHEL-5 antibodies, avidin-alkaline phosphatase
conjugates and BCIP-NBT substrate. (b) SEM image of 40 nm gold particles conjugated with anti-NVLP antibodies held down by NVLP captured on
patterned polyclonal anti-NVLP antibodies. (c) SEM images of biotinylated lysozyme captured on patterned HyHEL-5 antibodies detected using
nucleation by silver staining of streptavidin-gold conjugates, and their corresponding retroreﬂector (RR) optical read-out, which is the ratio of the
brightness of the assay reﬂector and the average of the three reference reﬂectors.
IL) in dimethylsulfoxide, DMSO (472301, >99.9%, ACS
reagent, Sigma-Aldrich, St. Louis, MO) and were allowed
to incubate for at least 30 minutes at room temperature.
Afterwards, the surfaces were washed once with DMSO,
then twice with DI water. Protein solution (at least 1
mg/mL in phosphate-buﬀered saline, 1× PBS) was imme-
diately spotted on the surfaces and allowed to incubate
for at least 2 hours at room temperature. Finally, sur-
faces were washed twice with 1× PBS, then thrice with
DI water.
Helium-beam exposure of antibody-functionalized
surfaces
A mixed beam of helium ions and atoms was generated
by a saddle-ﬁeld source based on the designs in refs.
[20,21]. The source is mounted onto a vacuum chamber
and helium gas is introduced at a pressure of a few mTorr.
When a high-voltage DC signal (3–10 kV) is applied,
electrons are trapped along oscillating paths through the
center of the source and can collide with the gas molecules
to ignite a plasma. A fraction of the ions can leave the
source with an energy of about 70% of source power sup-
ply potential, and some of these ions are neutralized when
colliding with background gasses by charge-exchange col-
lisions [22]. The beam, now consisting of ions and atoms,
then drifts to an exposure chamber located about 1.5 m
from the source. A mechanical shutter allows for auto-
mated timing of exposures, and the sample is placed on
a motorized x − y stage that allows for step-and-repeat
patterning of larger surfaces or for the patterning of a
number of individual samples with varying doses. A mask
can be placed in front of the sample to form a pre-deﬁned
nano-scale pattern or the sample can be placed on a
wedge-shaped sample holder to expose it to the beam at a
speciﬁc angle.
Patterning of proteins on surfaces was accomplished
by casting shadows either using a mask in proximity to
the surface (Figure 2a) or using the 5 μm tall retrore-
ﬂector structures on surfaces placed at an angle to the
beam (Figure 2b). The ion source discharge was operated
at 6 kV and 0.5 mA, which generated a beam with an
equivalent current density of about 70 nA/cm2, and the
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exposure time was varied from 15 seconds to 15 minutes,
corresponding to a dose range of about 1 to 75 μC/cm2.
After beam exposure, most surfaces were further passi-
vated with 4% bovine serum albumin, BSA (A7906, Sigma-
Aldrich, St. Louis, MO) in 1× PBS for at least 1 hour
at room temperature with mixing on an orbital shaker,
except for those surfaces used for studying beam-induced
antibody modiﬁcation.
Detection and visualization of proteins
Patterned antibodies were visualized using three methods
that have been utilized in various biomolecular assays,
1. enzyme-mediated formation of diformazan
precipitates by alkaline phosphatase (AP) from its
substrate bromochloroindoyl phosphate-nitroblue
tetrazolium BCIP-NBT,[23-25],
2. formation of silver nanoparticles by horseradish
peroxidase (HRP) EnzMet silver staining kit [26-29],
and
3. binding of gold nanoparticle probes (colloidal gold
conjugated with antibodies) [30-32] or gold
nanoparticle-nucleated silver enhancement [33-35].
Localized formation of diformazan precipitates used AP
conjugates (avidin-conjugated AP, 21321, Pierce Protein
Research Products, Rockford, IL) and BCIP-NBT (72091,
Sigma-Aldrich, St. Louis, MO). Gold nanoparticle probes
(20-PC-40 or 20-PC-100, both fromNanopartz Inc., Love-
land, CO) were conjugated with antibodies according
to the manufacturer’s protocol. Gold nanoparticle-
nucleated silver enhancement used streptavidin-gold con-
jugates (NanogoldTM, 2016, Nanoprobes, Yaphank, NY).
The silver staining kit consisted of HRP-mediated sil-
ver enhancement utilizing streptavidin-polyHRP conju-
gates (65R-S105PHRP, Fitzgerald Industries International,
Acton, MA) and HRP silver staining solution (EnzMetTM,
6010, Nanoprobes Inc., Yaphank, NY). The silver enhance-
ment solution was composed of 6 mM silver acetate
(85140, Sigma-Aldrich, St. Louis, MO) in DI water and
22.5 mM hydroquinone (H9003, Sigma-Aldrich, St. Louis,
MO) in citrate buﬀer (0.14 mM citric acid, 0.09 mM
sodium citrate, pH 3.8). Surfaces were incubated with
detection conjugates for 1 hour by mixing on an orbital
shaker at room temperature, and patterns were formed
through a staining step lasting 30 minutes to 1 hour for
formation of diformazan precipitates, at least 18 hours for
the binding of gold nanoparticle probes, 10 to 15 minutes
for gold nanoparticle-nucleated silver enhancement and 2
minutes for each reagent in HRP-mediated silver staining.
For sandwich assays, E. coli bacteria (K12 JM109),
Norwalk virus-like particles (NVLP), and hen egg white
lysozyme (L6876, Sigma-Aldrich, St. Louis, MO) were
used as antigen targets. Targets were captured on the
surface by immersing the antibody-coated sample in a
solution containing the antigen, and incubating at least 1
hour (12 hours for bacteria) at room temperature while
mixing on an orbital shaker. After capture, surfaces were
washed twice with 1× PBS followed by the detection
methods described in the previous paragraph.
Results and discussion
Patterned antibody inactivation through stencil masks
We tested the patterned deactivation procedure on pla-
nar surfaces by exposing samples through a stencil mask
consisting of 45 μm openings on a 90 μm pitch, as
shown schematically in Figure 2a. Gold planar surfaces
were covalently coupled with both monoclonal (mouse
HyHEL-5) and polyclonal (biotinylated goat anti-rabbit)
antibodies, exposed to the helium beam, and dipped in the
BSA solution to passivate the exposed areas. In Figure 3a,
patterned HyHEL-5 murine monoclonal antibodies were
detected by speciﬁc binding of secondary antibodies (anti-
mouse antibodies conjugated with alkaline phosphatase)
and visualized by conversion of BCIP-NBT to diformazan
precipitates. This optical image shows that the precipitate
accumulates on the beam-protected/unexposed regions
(the dark areas in the image), while the exposed regions
showed no precipitate (light areas). A similar result was
obtained for polyclonal antibodies, as shown in an SEM
image in Figure 3b, where the biotinylated goat anti-rabbit
antibodies were detected by silver staining of streptavidin-
gold conjugates. The image shows that the unexposed
regions form silver deposits, as the antibodies remained
functional, while the exposed regions were fully passivated
by the BSA.
Antibody capture of bacteria showed similar results. In
this experiment, a surface bearing immobilized polyclonal
anti-E. coli antibodies was patterned using the same mask
and was dipped into the BSA solution. After enzyme cap-
ture and BCIP-NBT staining, the bacteria were seen in the
unexposed regions, as is shown in Figure 3c. This result
again conﬁrms that antibodies protected from the helium
beam exposure retained their functionality and shows that
micron-scale bacteria can be selectively captured on the
unexposed regions. Moreover, the darkening is observed
only on the surface of the bacterium, not on the surfaces
adjacent to the bacteria, making the bacterium itself a
distinctive light-scattering object that can be detected by
the facile automated observation of a single retroreﬂector
structure.
Patterning of 3D structures
To form the patterned retroreﬂector readout illustrated in
Figure 1a, samples were exposed to the helium beam at
an angle, as shown in the schematic diagram in Figure 2b.
For completeness, this would be done from two angles to
ensure that both the front and the back of the structures
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Figure 5 Eﬀects of helium beammodiﬁcation of antibody and BSA, and BSA passivation: protein patterning by helium-beam exposure
through amask with 70μmopenings and 110 μm spacing. (I) Optical microscope images of patterns formed by gold nanoparticle-nucleated
silver enhancement on surfaces (a) passivated with BSA after beam exposure and incubated with biotinylated lysozyme followed by
streptavidin-gold conjugate, or (b) incubated with PBS (no BSA and no lysozyme) after beam exposure and incubated with streptavidin-gold
conjugate, or (c) passivated with BSA (no lysozyme) after beam exposure and incubated with streptavidin-gold conjugate. (II) Optical microscope
images of patterns formed by 100 nm gold nanoparticle probes on surfaces (d) passivated with BSA after beam exposure, or (e) incubated with PBS
(no BSA) after beam exposure, or (f) no PBS pre-incubation.
are properly passivated. During the development work
described here, however, surfaces were exposed at only
one angle to speed processing, and so the areas behind
the retroreﬂectors still have active antibodies. This can be
seen in the tails behind the two top reference reﬂectors
and the assay reﬂector in every tetrad shown in Figure 4a,
where polyclonal anti-mouse antibodies protected from
the beam were visualized through the localized formation
of diformazan precipitates.
Figure 4b and Figure 4c show the detection of Norwalk
virus-like particles (NVLP) and lysozyme, respectively.
Selective binding of gold nanoparticle labels (conju-
gated with polyclonal anti-NVLP antibodies) in the assay
region was observed, which conﬁrms the presence of
captured Norwalk VLPs. Successful capture of biotiny-
lated lysozyme (pre-mixed with streptavidin-gold con-
jugates) was conﬁrmed by gold nanoparticle-nucleated
silver enhancement. As observed in the retroreﬂector (RR)
optical read-out, which is also shown with the overlaid
relative intensities, localized deposition of silver nanopar-
ticles darkened the assay reﬂector by about 30% (i.e., the
ratio of assay reﬂector brightness to the average reference
reﬂectors changed from 1.10 to 0.77 for the control and
the silver stained samples, respectively). Figure 4c also
shows that nonspeciﬁc silver particles were formed on
areas other than the assay region, which is attributed to
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Figure 6 Evaluation of the resolution of the system by helium-beam exposure of antibody-coated surfaces through amask containing
300nm diameter openings. (a-b) SEM images of patterns formed by beam exposure of HyHEL-5 antibodies followed by BSA passivation, then
treated with biotinylated lysozyme followed by streptavidin-gold conjugate and silver enhancement. (d-e) SEM images of patterns formed by beam
exposure of HyHEL-5 antibodies followed by PBS (no BSA), then treated with streptavidin-polyHRP conjugate and silver enhancement. (c) and (f) are
images are the corresponding control surfaces.
the nonspeciﬁc binding of either lysozyme or streptavidin-
gold conjugates and not to silver formation in solution, as
the control surface (silver-stained, but without lysozyme-
nanoparticle complexes) had very few silver particles. This
nonspeciﬁc silver formation also slightly darkens the ref-
erence reﬂectors, but does not signiﬁcantly aﬀect the
read-out. This is because the reported values are ratios
of the assay reﬂector brightness to the average brightness
of three reference reﬂectors. This inherent self-calibration
minimizes the eﬀect of any nonspeciﬁc staining and
improves the reliability of the assay.
Chemical modiﬁcation mechanism
While the process of forming reference and assay detec-
tors works well, it was not clear what the mechanism for
the passivation of the exposed surfaces is. In order to help
understand this, the following sets of experiments, which
employ pattering through a stencil mask, were designed:
HyHEL-5 monoclonal antibodies were coupled to a gold-
coated silicon surface via the DSP crosslinker and then
exposed to helium beam through a stencil mask with 70
μmopenings on a 110μmpitch. After beam exposure, the
surfaces were
1. dipped into BSA solution, then incubated with
biotinylated lysozyme followed by streptavidin-gold
conjugate (Figure 5a),
2. immersed in PBS buﬀer (with no BSA and no
lysozyme) and incubated with streptavidin-gold
conjugate (Figure 5b), or
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3. dipped into BSA solution (no lysozyme) and
incubated with streptavidin-gold conjugate
(Figure 5c).
All surfaces were then silver-stained. Figure 5a shows
a pattern similar to those presented in Figure 3, where
the darkening of the unexposed, protected areas signi-
ﬁes the localized formation of silver nanoparticles while
the antibodies in the exposed regions were destroyed, and
the chemically-activated surfaces eﬀectively passivated by
BSA (light areas). A negative tone pattern was observed
in Figure 5b where only the exposed regions showed
localized unselective capture of silver nanoparticles (dark
areas) while the protected areas remained unreactive. This
indicates that, in the absence of BSA, the exposed regions
show favorable binding to the streptavidin-gold conju-
gate. Figure 5c again veriﬁes that exposed regions were
well-passivated by BSA since it prevented the subsequent
attachment of streptavidin-gold conjugate on these areas.
In the second column of Figure 5, surfaces that were
“decorated” with BSA via the DSP crosslinker were
exposed to the helium beam using the same mask, and
patterns were detected and visualized using 100 nm
gold nanoparticles conjugated with polyclonal anti-mouse
antibodies. No pattern was observed in Figure 5d, which
indicates that the unexposed regions (beam-protected
BSA) and beam-exposed areas (further incubated with
BSA) were both well-passivated. As shown in Figure 5e,
in the absence of BSA after beam exposure, gold nanopar-
ticle probes accumulated on the exposed regions, giving
the same pattern as in Figure 5b. This again suggests
that beam-exposed regions are reactive towards gold
nanoparticle-protein conjugates. Moreover, even with-
out the PBS pre-incubation, gold nanoparticle probes
still assembled on beam-exposed regions as shown in
Figure 5f. These results indicate that the high contrast
shown in Figure 3 and Figure 4 is due to BSA passivat-
ing the beam-exposed regions, which are highly active in
nonselective capture of proteins when unpassivated.
Spatial resolution
To evaluate the spatial resolution of this process, a sten-
cil mask containing 300 nm openings with 1 μm spac-
ing was used. The results are shown in Figure 6, where
HyHEL-5 antibodies were covalently immobilized on pla-
nar gold surfaces via the DSP crosslinker and exposed to
the beam through this mask. After exposure, one sam-
ple was immersed in BSA solution, followed by addi-
tion of biotinylated lysozyme and then streptavidin-gold
conjugate (Figure 6a) while another sample was dipped
in streptavidin-polyHRP conjugate solution (Figure 6b).
Both of these samples were then silver-stained. Figure 6a
shows that patterns were formed by the silver nanopar-
ticles in areas where antibodies were protected from the
beam. These patterned antibodies were still active as is
evidenced by the captured biotinylated lysozyme detected
through streptavidin-gold conjugate and visualized by
gold nanoparticle-nucleated silver enhancement. Figure 6b
shows similar results as before in that the exposed regions
non-speciﬁcally capture protein, and demonstrates the
very high spatial resolution of this approach to surface
patterning.
Conclusions
In this study, we have demonstrated the use of a high-
throughput collimated helium beam to pattern antibody-
coated surfaces (1) through a stencil mask and (2) by using
the geometry of existing three dimensional retroreﬂec-
tor structures to form self-aligned patterns. The results
show that, when the exposed surfaces are passivated with
BSA after beam exposure, there is an extremely high con-
trast between the exposed and the protected regions of
antibody-modiﬁed surfaces. While the exposed regions
are well-passivated, the beam-protected (unexposed) anti-
bodies remain functional and allowed for the detection of
lysozyme, Norwalk virus-like particles and E. coli bacteria.
We have also established that helium beam exposuremod-
iﬁes the antibodies (and other proteins, in this case, BSA)
such that they readily capture other proteins (such as BSA
for passivation, but also streptavidin and secondary anti-
bodies for contrasting functionality). Helium beam expo-
sure followed by BSA passivation of antibody-modiﬁed
surfaces can be used to pattern active antibodies with a
resolution of at least 300 nm. The localized passivation of
antibodies is also well-suited for forming retroreﬂecting
sensor elements whose relative brightness indicates the
presence of a scattering material and which can be used as
sensitive readouts for bioassays.
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